| Bid Price | 1412.60p | High Price | 1414.99p |
|---|
| Ask Price | 1413.00p | Low Price | 1380.20p |
|---|
| Open Price | 1385.80p | Spread | 0.03% |
|---|
| Prev Close | 1393.40p | Volume | 8,143,685 |
|---|
Glaxosmithkline PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Jan 15, 2021 | 1385.80 | 1414.99 | 1380.20 | 1413.60 | 8,143,685 |
| Jan 14, 2021 | 1370.60 | 1396.60 | 1365.40 | 1393.40 | 18,540,081 |
| Jan 13, 2021 | 1360.20 | 1378.40 | 1360.20 | 1372.60 | 12,852,647 |
| Jan 12, 2021 | 1395.40 | 1399.00 | 1367.00 | 1367.00 | 9,822,376 |
| Jan 11, 2021 | 1405.20 | 1413.00 | 1390.80 | 1395.00 | 7,685,266 |
Glaxosmithkline PLC Information
| Name | Glaxosmithkline PLC | Epic | GSK |
|---|
| ISIN | GB0009252882 | Currency | GBX |
|---|
| Type | Equity | Trading Segment | SET1 |
|---|
| Record Status | Active | Trading Status | Closed |
|---|
| Industry | Drug Manufacturers - General | Sector | Healthcare |
|---|
| EMS | 1,000 | Prev Close | 1393.40p |
|---|
| Shares in Issue (m) | 5.03 bn | Market Cap | £71.10 bn |
|---|
| PE Ratio | 11.025358 | Div per Share | £0.61 |
|---|
| Div Yield | 5.74 | Div Cover | 1.6508 |
|---|
| EPS | £1.01 | EPS Growth (%) | n/a |
|---|
| PEG | n/a | DPS Growth (%) | 0 |
|---|
| ROCE | 0.032192 | Quick Ratio | 0.550972 |
|---|
| Current Ratio | 0.896388 |
|---|
Glaxosmithkline PLC Director Deals
| Date | Director | Deal type | Number of shares dealt | Price | Value of trade |
|---|
| 15/01/2021 | Ms. Emma N. WalmsleyExecutive Director,Chief Executive Officer | In lieu of Dividend | 28 | £13.87 | £388 |
| 13/01/2021 | Ms. Emma N. WalmsleyExecutive Director,Chief Executive Officer | Purchase | 9 | £13.84 | £125 |
| 13/01/2021 | Ms. Emma N. WalmsleyExecutive Director,Chief Executive Officer | Transfer in | 9 | £0.00 | £0 |
| 11/01/2021 | Dr. Hal V Barron Executive Director,Chief Scientific Officer and President, RandD | Purchase | 2,170 | $19.04 | $41,306 |
| 11/01/2021 | Dr. Hal V Barron Executive Director,Chief Scientific Officer and President, RandD | Purchase | 388 | $19.04 | $7,386 |
Glaxosmithkline PLC News
